ORGANOVO HOLDINGS INC (ONVO) Stock Price & Overview
NASDAQ:ONVO • US68620A2033
Current stock price
The current stock price of ONVO is 2.04 USD. Today ONVO is up by 1.49%. In the past month the price decreased by -28.17%. In the past year, price decreased by -83%.
ONVO Key Statistics
- Market Cap
- 3.468M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.49
- Dividend Yield
- N/A
ONVO Stock Performance
ONVO Stock Chart
ONVO Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ONVO. When comparing the yearly performance of all stocks, ONVO is a bad performer in the overall market: 97.68% of all stocks are doing better.
ONVO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ONVO. ONVO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
ONVO Earnings
On February 19, 2025 ONVO reported an EPS of -2.29 and a revenue of 24.00K. The company beat EPS expectations (10.83% surprise) and missed revenue expectations (-46.52% surprise).
ONVO Forecast & Estimates
For the next year, analysts expect an EPS growth of 96.31% and a revenue growth 126.67% for ONVO
ONVO Groups
Sector & Classification
ONVO Financial Highlights
Over the last trailing twelve months ONVO reported a non-GAAP Earnings per Share(EPS) of -4.49. The EPS increased by 60.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -322.19% | ||
| ROE | -3402.47% | ||
| Debt/Equity | 0 |
ONVO Ownership
ONVO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.07 | 369.265B | ||
| AMGN | AMGEN INC | 15.24 | 187.564B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 173.439B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.63 | 111.445B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.3 | 80.543B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.73 | 42.286B | ||
| INSM | INSMED INC | N/A | 35.012B | ||
| NTRA | NATERA INC | N/A | 29.477B | ||
| BIIB | BIOGEN INC | 11.03 | 26.026B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.91 | 24.756B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.643B | ||
| MRNA | MODERNA INC | N/A | 19.431B | ||
| INCY | INCYTE CORP | 12.53 | 19.091B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ONVO
Company Profile
Organovo Holdings Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California and currently employs 20 full-time employees. The company went IPO on 2013-08-02. Organovo Holdings, Inc. is a clinical-stage biotechnology company. The firm is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. The company focuses on developing novel treatment approaches in inflammatory bowel disease (IBD). The firm has proprietary technology used to build 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The company uses its proprietary technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. Its Mosaic division to serve as a key source of certain primary human cells it utilizes in its research and development efforts. Its 3D human tissue platform is multifaceted. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters.
Company Info
IPO: 2013-08-02
ORGANOVO HOLDINGS INC
Suite 100, 11555 Sorrento Valley Road
San Diego CALIFORNIA 92075 US
CEO: Keith Murphy
Employees: 20
Phone: 18582241000
ORGANOVO HOLDINGS INC / ONVO FAQ
What does ORGANOVO HOLDINGS INC do?
Organovo Holdings Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California and currently employs 20 full-time employees. The company went IPO on 2013-08-02. Organovo Holdings, Inc. is a clinical-stage biotechnology company. The firm is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. The company focuses on developing novel treatment approaches in inflammatory bowel disease (IBD). The firm has proprietary technology used to build 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The company uses its proprietary technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. Its Mosaic division to serve as a key source of certain primary human cells it utilizes in its research and development efforts. Its 3D human tissue platform is multifaceted. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters.
What is the stock price of ORGANOVO HOLDINGS INC today?
The current stock price of ONVO is 2.04 USD. The price increased by 1.49% in the last trading session.
What is the dividend status of ORGANOVO HOLDINGS INC?
ONVO does not pay a dividend.
How is the ChartMill rating for ORGANOVO HOLDINGS INC?
ONVO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Should I buy ONVO stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ONVO.